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Until the Health Professions Council 
of South Africa (HPCSA) comes up 
with acceptable tariff guidelines or the 
courts definitively rule on the validity 
of regulations governing prescribed 
minimum benefits (PMBs), internecine 
warfare in the healthcare industry is set to 
continue.
That is the effect of last month’s dismissal 
by the Supreme Court of Appeal (SCA) of 
an application by the Board of Healthcare 
Funders (BHF) to have declared invalid a year-
old finding by the High Court in Pretoria. In 
November last year, Judge Cynthia Pretorius 
found that the BHF had no locus standi1 to ask 
for a ruling on the correct interpretation of 
Regulation 8 of the Medical Schemes Act. She 
ordered that the BHF pay what will amount 
to several million rands in costs for senior 
counsel representing 13 respondents, which 
included the Council for Medical Schemes 
(CMS), the National Minister of Health, 
the Pharmaceutical Society of South Africa, 
Medi-Clinic SA Ltd, Multiple Sclerosis South 
Africa, National Renal Care and the South 
African Medical Association. That hefty legal 
bill must now be paid and, Izindaba reliably 
learns, there is a high probability that the BHF 
will change tack and make yet another court 
bid, this time challenging the legal validity of 
Regulation 8 – so problematic is it to their 
members.
Application ‘fatally 
defective’
In the original court case Judge Pretorius 
said there was merit in the CMS’s contention 
that the ‘non-joinder’ of all medical schemes 
in papers submitted by the BHF (it cited only 
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15 of the claimed 75 members) rendered 
the application fatally defective. She said all 
medical schemes should have been joined as 
the judgement would have a direct impact on 
them all (both the Medical Schemes Act and 
its Regulations refer to all medical schemes 
in South Africa).
A court ruling on the gaping chasm in 
the interpretation of Regulation 8 would 
bring to an end a four-year dispute between 
the BHF, which represents most medical 
schemes, and the CMS – the regulatory 
supervisor of private healthcare financing. 
The conflict ramped up in a test case in 
November 2008 when the CMS’s Appeal 
Board ruled that service providers must 
‘pay in full’ all invoices related to the costs 
of providing healthcare services for PMBs 
– without taking the rules of the respective 
medical scheme into consideration. These 
rules significantly diminish their liability 
and, argues the BHF, are fundamental 
to the future existence of its member 
schemes.
In a testy response to the SCA ruling, Dr 
Humphrey Zokufa, MD of the BHF, asked 
why the other respondent organisations in 
the court hearing had not had their locus 
standi questioned, claiming the ruling set a 
‘severely negative’ precedent for other major 
industry representative organisations wishing 
to act on behalf of their members, such as the 
Chamber of Mines, BUSA (Business Unity, 
South Africa) and SANTACO (the South 
African National Taxi Council).
Significance of issue 
underrated by courts: 
Zokufa
‘We’d like to believe that we operate in 
a country where constitutional rights are 
taken seriously and the justice system is 
fair. However, we do not feel that this case 
has been given the necessary significance 
to demonstrate fairness by the courts. We 
therefore consider it our duty to explore 
ways of taking this matter forward in a 
responsible and constructive way, as we have 
done in the past,’ he said.
Izindaba interviews with players in the 
saga revealed that it is unlikely the BHF will 
take the SCA ruling to the Constitutional 
Court, given that Judge Pretorius found 
the section relevant to locus standi in the 
Constitution inapplicable in her judgement. 
BHF spokesperson Heidi Kruger said 
that if the HPCSA had managed to set 
maximum tariff guidelines which ‘everybody 
agreed on, it would allay many of the current 
problems. But the history of Regulation 
8 is that the CMS says medical schemes 
have to pay whatever the doctor charges. 
It amounts to open-ended liability.’ In the 
current uncertain climate, doctors charge 
whatever they choose while medical aids pay 
doctors out at their own (medical aid) rates, 
leaving the patient to make co-payments or 
negotiate the doctor’s tariff downward.
Without tariff 
guidelines, litigation ‘the 
only way’ – BHF
Kruger told Izindaba that there had been ‘no 
option’ but to take the matter to the SCA. 
‘We had to take it to its ultimate end. Now 
we’re weighing up the best way to take the 
issue forward. While there is no tariff we 
must pursue legal options. The HPCSA tariff 
process must include one universal coding 
and tariff system for the entire industry, one 
that is fair and affordable for all.’
Asked what she and Zokufa meant by 
‘exploring legal options’ and ‘taking the 
matter forward’, she declined to rule out 
either an approach to the Constitutional 
Court or ‘another application on Regulation 
8’, confirming that the latter would probably 
test the regulation’s legal validity. 
In August this year, shortly after a BHF 
conference where speakers set the healthcare 
industry alight, the HPCSA issued a set of 
what SAMA labelled ‘highly unscientific’ 
low-ceiling tariff guidelines. They caused a 
furore among doctors, forcing the council 
back to the drawing board. A multi-
stakeholder HPCSA committee probing the 
real costs of healthcare and coding issues is 
being touted as the best way to come up with 
a more realistic set of tariff guidelines – but 
until then the BHF has vowed to forge ahead 
with court action.
Basic distrust between 
funders and providers 
In an exclusive interview with Izindaba 
at the BHF conference which ended in 
the Drakensberg on 1 August, Zokufa was 
asked about PMBs and the ‘free for all’ 
on tariffs in the absence of ‘consensus’ 
guidelines.1 He drew an analogy with 
companies manufacturing car parts 
but ‘having acrimony’ with car makers 
themselves. ‘They come up with a good 
product for my car. We decide on what is 
a good price. You survive and I survive. 
That’s not happening in this industry.’ He 
said that once the legislative framework for 
taking care of 8.2 million lives was set up, 
the industry failed to create an environment 
in which funders and providers saw each 
other as ‘being on the same side of the same 
coin, all targeting the patient’. The basic 
underlying problem included an absence of 
trust between funders and providers and a 
lack of transparency in the system. ‘Maybe 
healthcare has been steered too much to 
the commercial side of it … commercialism 
in health is then run along the lines of how 
people run a corporate business. I think 
we’ve gone overboard. There is a line in 
the sand that must not be crossed. I don’t 
think we know where that line is … I don’t 
think medical schemes and providers are 
sensitive to where that line is. It’s what 
drives the lack of trust,’ he added.
This is one money-driven soap opera that, 
like the TV drama Dallas, will run and run, 
especially as it tries to tap into opportunities 
and/or adapts to threats posed by the 
country’s biggest-ever oil well – National 
Health Insurance.
* locus standi – the ability of a party 
to demonstrate to the court sufficient 
connection to and harm from the law or 
action challenged to support that party’s 
participation in the case.
Chris Bateman
chrisb@hmpg.co.za
2. Bateman C. Private healthcare ‘lost line in the sand’– Zokufa. 
S Afr Med J 2012;100(10):776-777.[http://dx.doi.org/10.7196/
SAMJ.6253]
S Afr Med J 2012;102(11):819-820. 
DOI:10.7196/SAMJ.6359
Heidi Kruger, Head of BHF Corporate 
Communications.
